Patents
Patents for C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
08/2002
08/15/2002US20020111368 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
08/08/2002US20020107234 Lipoic acid derivatives and their use in treatment of disease
08/08/2002DE10105313A1 Verfahren zur Herstellung von Verbindungen mit einer CF20-Brücke Process for the preparation of compounds having a bridge-CF20
08/01/2002WO2002030918A3 PROCESS FOR THE PRODUCTION OF R(+)α-LIPOIC ACID
08/01/2002US20020103387 Compounds which mimic the chemical and biological properties of discodermolide
08/01/2002US20020103324 Polyisocyanate compounds, process for producing the same, and optical materials using the same
07/2002
07/31/2002EP0888334B1 2-hetaroylcyclohexane-1,3-diones
07/25/2002WO2002030917A3 Process for the production of racemic thioctic acid
07/25/2002WO2001093865A3 Medicaments for treating dementia
07/25/2002US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
07/25/2002DE10158803A1 Production of difluoromethoxy-bridged compounds, involves addition of acid to ketene dithioketal, reaction of the carbenium salt with hydroxy compound and fluorodesulfurisation of the dithio-ortho-ester
07/11/2002WO2002053522A2 Novel estrogen receptor ligands and methods i
07/11/2002US20020091210 Group 8-10 transition metal based supported catalyst where the support is treated with a pore-filling agent; improved the catalyst productivity in the presence of hydrogen
07/11/2002CA2433828A1 Novel estrogen receptor ligands and methods i
07/09/2002US6417009 Reservoir components
07/04/2002WO2002051774A1 Production of disubstituted tetrafluoroethylene derivatives
07/04/2002DE10065218A1 Herstellung von disubstituierten Tetrafluorethylen-Derivaten Preparation of disubstituted tetrafluoroethylene derivatives
07/03/2002EP0915837B1 Glyoxylic acid derivatives
07/03/2002CN1356977A Glucagon antagonists/inverse agonists
07/02/2002CA2047382C Stabilized monomer compositions
06/2002
06/27/2002WO2002024613A3 Resorcinol derivatives
06/20/2002WO2002048081A1 Liquid crystalline compounds
06/20/2002WO2002048073A1 Method for producing compounds having a cf2o bridge
06/20/2002US20020077347 For therapy of diabetes, obesity
06/19/2002EP1214933A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected
06/19/2002CN1354748A Method for production of solvent-free alpha-liponic acid
06/18/2002US6407136 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
06/13/2002WO2002046150A2 Compounds which mimic the chemical and biological properties of discodermolide
06/13/2002DE10061790A1 Flüssigkristalline Verbindungen Liquid-crystalline compounds
06/13/2002CA2431045A1 Compounds which mimic the chemical and biological properties of discodermolide
06/06/2002WO2002044163A2 Method for producing lipoic acid and dihydrolipoic acid
06/06/2002WO2002044111A1 Transfer hydrogenation process and catalyst
06/06/2002WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/06/2002US20020066888 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices
06/06/2002CA2430295A1 Transfer hydrogenation process and catalyst
06/06/2002CA2430073A1 Method for producing lipoic acid and dihydrolipoic acid
05/2002
05/30/2002US20020065192 Productivity catalysts and microstructure control
05/29/2002EP1207878A2 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof
05/29/2002CN1351581A Novel carboxylic acid derivatives and process for producing the same
05/29/2002CN1134400C Novel carboxylic acid derivatives and process for producing the same
05/23/2002WO2001083571A3 Catalysts containing n-pyrrolyl substituted nitrogen donors
05/23/2002US20020061995 Acrylic ester compound and usage thereof
05/16/2002US20020058768 For use in addition polymerization of olefins
05/16/2002US20020056827 Piezoelectric element and process for production thereof
05/15/2002CN1349523A Novel lipoic acid derivatives, their prepn., and pharmaceutical compositions containing them
05/14/2002US6387945 Lipoic acid analogs
05/10/2002WO2002036641A2 Improved productivity catalysts and microstructure control
05/10/2002WO2002036585A2 Process for the preparation of ligands for olefin polymerization catalysts
05/10/2002WO2002036533A1 Monomers having electron-withdrawing groups and processes for preparing the same
05/09/2002US20020055045 Novel materials useful as electrolytic solutes
05/08/2002EP1202983A1 Method for the production of a solvent-free alpha- liponic acid
05/07/2002US6384289 Reacting a 1,4-bis/1,3-dioxa-, dithia- or oxathia- 4,5, or 6-member cycloalk-2-yl/benzene, a fluorinating compound and a bromine-containing compound in a solvent at low temperatures; simplification
05/02/2002WO2002034740A1 Method for producing cyclic carboxylic orthoester fluorides and corresponding compounds
05/02/2002WO2001085165A3 Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system
05/02/2002US20020052400 Substituted O- and/or S heterocyclic compounds; powerful ligands for melatoninergic receptors.
05/01/2002CN1346829A Acrylate compounds and use
04/2002
04/30/2002US6379590 Method for making unsymmetrically substituted fluorenyl compounds for nonlinear optical applications
04/30/2002CA2059787C Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient
04/25/2002WO2002032377A2 Estrogen receptor modulators
04/25/2002US20020049289 Novel (thio) (meth) acrylate monomers, intermediate compounds for the synthesis of these monomers polymerizable compositions and polymers obtained, and their optical and ophthalmic uses
04/25/2002US20020049135 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
04/25/2002US20020048798 For therapy and prophylaxis of inflammatory, proliferative and degenerative diseases, e.g. diabetes mellitus, atherosclerosis, Alzheimer's disease and non-pathological conditions such as skin aging and wrinkle formation
04/25/2002CA2424729A1 Estrogen receptor modulators
04/24/2002CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
04/23/2002CA2109050C Rs-thioctic acid with novel morphology
04/18/2002WO2002030919A1 SYNTHESIS OF R(+)α-LIPOIC ACID
04/18/2002WO2002030918A2 PROCESS FOR THE PRODUCTION OF R(+)α-LIPOIC ACID
04/18/2002WO2002030917A2 Process for the production of racemic thioctic acid
04/16/2002US6372682 Contacting one or more olefin monomers with a group 8-10 transition metal complex catalyst and optionally a bronsted or lewis acid
04/11/2002US20020042444 Treatment of lipid metabolic disorders using 5-(1,2-dithiolan-3-yl) valeric acid (alpha-lipoic acid) or its physiologically compatible salts
04/09/2002US6369098 Peroxisome proliferator-activated receptor-.gamma. (ppar.gamma.) and/or ppar.alpha treatment of endocrine, skin, cardiovascular, immunological, neurological, neuropsychiatric, neoplastic and chronic viral diseases of various organs
04/09/2002US6369071 Treatment of angina pectoris
04/04/2002WO2002026909A1 Compositions and methods for thionation during chemical synthesis reactions
04/03/2002EP1193264A1 Acrylic ester compound and usage thereof
04/03/2002EP1192149A2 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
04/03/2002CN1343206A Cyclocompound
04/02/2002US6365623 Treatment of acne using lipoic acid
04/02/2002US6365579 Nitrate esters and their use for neurological conditions
04/02/2002US6365301 Delocalized nitrogen, oxygen, sulfur or phoshorous onium cation; bis-fluorosulfonimidide anion or bis-difluorophos-phonylamidide anion
04/02/2002US6365195 Fungicidal active compound combinations
03/2002
03/28/2002WO2002024613A2 Resorcinol derivatives
03/28/2002CA2423262A1 Resorcinol derivatives
03/27/2002EP1191611A2 Piezoelectric element and process for production thereof
03/26/2002CA2041588C Cyclohexenone oxime ethers, their preparation, intermediates for their preparation and their use as herbicides
03/21/2002WO2002022694A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
03/21/2002US20020035114 Substituted dimeric compounds
03/21/2002US20020035030 Contacting alpha-olefin with ransition metal complex of and Bronsted or Lewis acid to produce polyolefin
03/21/2002DE10044000A1 Preparation of R- or S-lipoic acid via R- or S-dihydrolipoic acid useful in the pharmaceutical and food industries involves e.g. reaction of 6,8-bis(sulfonyloxy)-octanoate with sodium sulfide and sulfur and treatment with complex hydride
03/21/2002CA2421054A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
03/13/2002EP1185257A2 Treatment of acne using lipoic acid
03/12/2002US6355806 Regulators of cell proliferation and differentiation, agents for treating skin-related diseases
03/07/2002US20020028796 Adjustment mineral concentration
03/06/2002EP1183229A1 Glucagon antagonists/inverse agonists
02/2002
02/27/2002EP1182186A2 Difluoromethyl ether derivative and process for producing the same
02/27/2002CN1337228A Application of lipoic acid for improving biological utilization ratio of mineral salt
02/21/2002DE10038038A1 Preparation of R- or S-lipoic acid via R- or S-dihydrolipoic acid useful in the pharmaceutical and food industries involves e.g. reaction of 6,8-bis(sulfonyloxy)-octanoate with sodium sulfide and sulfur and treatment with complex hydride
02/13/2002EP0873333B1 Phenyl benzyl ethers, process for producing them and their use as pesticide and fungicide
02/07/2002US20020016311 Nitrate esters and their use for neurological conditions
02/07/2002DE10036516A1 Verfahren zur Herstellung von enantiomerenreinen 6,8-Dihydroxyoctansäureestern durch assymetrische katalytische Hydrierung A process for the preparation of enantiomerically pure 6,8-dihydroxyoctanoic acid esters by asymmetric catalytic hydrogenation
02/05/2002US6344561 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 34